After buying Novan's assets, Ligand crosses FDA finish line with molluscum gel Zelsuvmi
Fierce Pharma
JANUARY 7, 2024
Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval. | Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval.
Let's personalize your content